You sound new to MSB. Most of us have been here for over 5yrs. Even those like me who hold are critical of cheer leaders promising the world to new investors. Comments like when will MSB buy CSL is ridiculous.
In a nutshell fundies analysts (based on expected sales/profitablity/COTS) is;
aGVHD which was voted in favor today $2 - $3 increase to SP. So considering our trading range was $3.20 - $4 you can add the increase to that. FDA approval was always expected as it is currently used and approved in Japan.
CHF (chronic heart failure) expected phase 3 result in Sept/Oct (well mid year actually but seems not) $5 - $10, less chance of FDA approval.
Covid-ARDS (rocket ship trial), could be $100 - $200 increase... the golden egg, hardest to get FDA approval of course.
Hope this helps you temper your expectations at this stage with more realistic prices. Cheer leaders will say whatever to convince others to boost their profits; shamless.
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-472
-
- There are more pages in this discussion • 12,599 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1335 | 1.160 |
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online